T.12.9 EARLY HEPATIC DECOMPENSATION IDENTIFIES PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB PLUS BEVACIZUMAB OR SORAFENIB AT HIGHEST RISK OF DEATH
作者
C. Celsa,G. Cabibbo,Salvatore Battaglia,M. Enea,G. Di Maria,Alessandro Grova,Roberta Ciccia,Giulia Francesca Manfredi,M. Iavarone,Arndt Vogel,Amit Singal,María Reig,D.J. Pinato,Calogero Cammà